tiprankstipranks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN

Eledon Pharmaceuticals (ELDN) Financial Statements

742 Followers

Eledon Pharmaceuticals Financial Overview

Eledon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.485; its P/E ratio is -1.82; Eledon Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.29M$ -9.63M$ -10.35M$ -9.58M$ -10.77M
EBITDA$ -10.20M$ -9.53M-$ -9.48M$ -10.68M
Net Income Common Stockholders$ -10.29M$ -9.63M$ -10.35M$ -9.58M$ -10.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 42.86M$ 51.10M$ 59.61M$ 71.38M$ 46.48M
Total Assets$ 80.82M$ 89.07M$ 96.07M$ 106.78M$ 82.31M
Total Debt$ 284.00K$ 383.00K$ 479.00K$ 574.00K$ 668.00K
Net Debt$ -42.58M$ -50.72M$ -59.13M$ -70.80M$ -45.82M
Total Liabilities$ 6.00M$ 5.65M$ 4.73M$ 6.84M$ 7.51M
Stockholders Equity$ 74.82M$ 83.42M$ 91.33M$ 99.95M$ 74.79M
Cash Flow-
Free Cash Flow$ -8.74M$ -9.13M-$ -8.22M$ -9.92M
Operating Cash Flow$ -8.74M$ -9.13M$ -12.25M$ -8.22M$ -9.92M
Investing Cash Flow$ 9.78M$ 10.08M$ -25.03M$ -30.33M-
Financing Cash Flow$ 1.00K--$ 33.02M-
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Eledon Pharmaceuticals Debt to Assets

Eledon Pharmaceuticals Cash Flow

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis